1-3 of 3
Guoqiang Liu
Close
Sort by
Journal Articles

Orelabrutinib in Combination with Rituximab and Chemotherapy for Newly Diagnosed Aggressive B-Cell Lymphoma: A Multicenter, Single-Arm, Prospective Study

Xiangxiang Zhou, Xiaoqian Liu, Yurou Chu, Xiaoxia Chu, Jie Li, Haiyan Zhang, Changyong Yuan, Xiuzhi Deng, Guoqiang Liu, XianQi Feng, Wei Wang, Zhaogang Sun, Xiaosheng Fang, Mei Ding, Dai Yuan, Xueling Ge, Ying Li, Xin Liu, Lingyan Zhang, Xin Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9544–9545.
https://doi.org/10.1182/blood-2022-169274
Published: 2022
Journal Articles

Recombinant Human Thrombopoietin (rhTPO) and High-Dose Dexamethasone (HD-DXM) Versus High-Dose Dexamethasone Monotherapy As Frontline Treatment in Newly Diagnosed Adult Immune Thrombocytopenia (ITP): a Prospective, Multicentre, Randomised, Controlled Trial

Miaomiao Wang, Ping Qin, Hai Zhou, Fang Zhou, Hongguo Zhao, Xin Wang, MD PhD, Ruirong Xu, Daqi Li, Lei Wang, Yuhong Zhou, Ying Feng, Mei Zhang, Lan Yang, Xiaomin Wang, Qingshu Zeng, Haiyan Zhang, Zhaogang Sun, Jingxia Wang, Guoqiang Liu, Xinhong Guo, Zhencheng Wang, Wenzheng Yu, Xiaoxia Chu, Chenglu Yuan, Kehong Bi, Yili Wang, Xuehong Ran, Jun Peng, Ming Hou, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 13.
https://doi.org/10.1182/blood.V130.Suppl_1.13.13
Published: 2017
Journal Articles

Conventional Oral Prednisone Versus High-Dose Dexamethasone for Management of Adult Immune Thrombocytopenia: A Prospective Randomized Multicenter Clinical Trial

Yu Wei, Xuebin Ji, Jingxia Wang, Enqin Yang, Zhengcheng Wang, Yuqi Sang, Zuomu Bi, Cuiai Ren, Fang Zhou, Guoqiang Liu, Xin Wang, Jun Peng, Ming Hou, MD
Journal: Blood
Blood (2014) 124 (21): 1455.
https://doi.org/10.1182/blood.V124.21.1455.1455
Published: 2014